Your new post is loading...
Research and publish the best content.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Already have an account: Login
Bioscience News - GEG Tech top picks
8.8K views |
+0 today
Combination immunotherapy with nivolumab and ipilimumab provided intracranial and extracranial responses for patients with melanoma and brain metastases, according to data from CheckMate 204 (ClinicalTrials.gov Identifier: NCT02320058) presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago